Sepsis Therapeutics Market Analysis North America, Europe, APAC, South America, Middle East and Africa - US, China, Japan, Germany, UK - Size and Forecast 2024-2028

Published: Nov 2023 Pages: 157 SKU: IRTNTR76822

Sepsis Therapeutics Market Forecast 2024-2028

The Sepsis Therapeutics Market is estimated to grow by USD 1.42 billion, at a CAGR of 6.98% between 2023 and 2028. The global sepsis incidence is alarming, affecting millions annually. Antibiotic resistance and invasive procedures worsen the crisis. Precision medicine emerges as a crucial market driver, tailoring therapies to individual patients. Genetic, molecular, and immunological profiles shape treatments. In sepsis therapeutics, precision medicine fosters therapeutic innovation and aids clinical trials.

Rising disease awareness fuels the demand for effective medical interventions. However, upfront expenses hinder market growth, posing a challenge. Precision medicine trends prioritize tailored sepsis care, optimizing patient care and disease management. Regulatory compliance and quality assurance remain essential for pharmaceutical companies.

What will be the Size of the Market During the Forecast Period?

To learn more about this report, Request Free Sample

Market Segmentation by Application, Type, and Geography Analysis

Application Analysis

Hospitals Segment

The hospitals segment is estimated to witness significant growth during the forecast period. The hospitals segment stands as the frontline institutions in the global market, representing critical hubs for the diagnosis, treatment, and management of sepsis cases. In addition, exemplary institutions like the Mayo Clinic, renowned for its patient-centered approach and innovative medical practices, showcase the comprehensive care provided to sepsis patients. Furthermore, the Cleveland Clinic, with its commitment to research-driven solutions and early intervention strategies, contributes significantly to improved sepsis outcomes.

Get a glance at the market contribution of various segments Download PDF Sample

The hospitals segment was the largest segment and was valued at USD 1.39 billion in 2018. Moreover, in hospitals, sepsis-therapeutics are administered across various departments, including emergency rooms, intensive care units (ICUs), and surgical wards, reflecting the urgency and complexity of sepsis-cases. In addition, these institutions prioritize protocols for prompt identification, aggressive treatment, and continuous monitoring, underscoring the crucial role hospitals play in combating sepsis. Furthermore, factors such as the ongoing advancements in hospital infrastructure, technological integration for swift diagnosis and treatment, and concerted efforts to enhance sepsis-awareness and management practices within these healthcare institutions globally are fueling the growth of this segment, which in turn drives the market growth during the forecast period.

Type Analysis

Antimicrobial therapy

The antimicrobial therapy segment is an essential aspect of Septicemia Therapy, comprising the use of medications to combat the underlying infectious agents. In addition, antibiotics play a central role in addressing bacterial infections associated with sepsis. Moreover, these drugs are administered through various routes, including intravenous, to ensure rapid and effective distribution throughout the body. In addition, timely initiation of antimicrobial therapy is pivotal, as it directly impacts the success of Septic Shock Intervention by halting the progression of the infection. Furthermore, advancements in precision medicine and a better understanding of microbial genomics are expected to fuel the evolution of antimicrobial therapy, ensuring its efficacy and relevance in the dynamic landscape of sepsis-treatment, which in turn drives the market growth during the forecast period.

Regional Analysis

For more insights about the market share of various regions Download PDF Sample now!

North America is projected to contribute 35% to the growth of the global market during the forecast period. Technavio’s analysts have extensively outlined the regional trends and drivers that will influence the market during this time. North America holds a pivotal role in the global sepsis treatment market, with the US and Canada emerging as major revenue contributors. The region boasts a highly advanced healthcare infrastructure, state-of-the-art medical research, and a robust regulatory framework. Institutions like the Mayo Clinic and Johns Hopkins Hospital in the US significantly contribute to advancements in sepsis diagnosis and treatment. Moreover, the region's high awareness among healthcare professionals and the public fuels the demand for effective therapeutics, thereby driving market growth in North America during the forecast.

Buy Full Report Now

Market Dynamics and Customer Landscape

The global incidence of sepsis is alarming, surpassing deaths from other diseases. Antibiotic resistance exacerbates the crisis, limiting treatment options. Precision medicine emerges as a market driver, tailoring therapies to patients' unique profiles. Genetic, molecular, and immunological factors shape treatment strategies. However, the growing threat of antimicrobial resistance poses a challenge.

Overuse and misuse of antibiotics contribute to resistant strains, narrowing treatment options. Effective hospital care and healthcare providers are crucial for patient management. Pharmaceutical companies play a key role in developing targeted therapies. Treatment guidelines and patient support groups aid in navigating treatment options.

Key Market Drivers

The global incidence of sepsis is alarming, driven by factors such as antibiotic-resistant infections and increased invasive medical procedures. Precision medicine emerges as a pivotal market growth driver, tailoring treatments based on patients' genetic, molecular, and immunological profiles.

According to the CDC, sepsis claims the lives of 350,000 adults annually in the US alone, affecting 1.7 million individuals, surpassing deaths from opioid overdoses, breast cancer, and prostate cancer combined. Additionally, over 75,000 children in the US suffer from severe sepsis each year. Factors such as antibiotic-resistant infections, increased invasive medical procedures, and an aging population with compromised immune systems contribute to this surge. The emphasis on precision medicine shapes market research and growth analysis, guiding market forecasting. Pharmaceutical companies play a crucial role in developing tailored therapies, emphasizing brand recognition and effective distribution channels.

Key Market Trends

A significant market growth trend is the rising emphasis on precision medicine in treating infectious diseases like sepsis. This approach tailors therapies based on individual patient characteristics, including genetic, molecular, and immunological factors. It aims to move beyond the conventional approach, optimizing interventions for better outcomes.

For instance, identifying genetic variations can guide targeted therapies, and precision medicine helps determine the most effective antimicrobial agents. As a result, such factors contribute to market growth analysis in the forecast period, shaping strategies in the pharmaceutical industry and driving advancements in adjunctive therapies like immunotherapy and vasopressors for early sepsis detection.

Key Market Challenges

The escalating challenge of antimicrobial resistance (AMR) poses a significant obstacle to market growth. AMR arises when microorganisms like bacteria, viruses, fungi, and parasites evolve to resist drugs intended to eradicate them. This resistance undermines the efficacy of antibiotics, crucial in treating bacterial infections. Excessive use and misuse of antibiotics in healthcare and agriculture expedite the emergence of resistant strains, amplifying the threat to public health.

Additionally, the limited availability of effective antibiotics restricts treatment options for sepsis patients, further impeding market growth drivers in the forecast period for pharmaceutical companies and providers of intravenous fluids.

Buy Now Full Report

Key Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 16 market companies, including:

Adrenomed AG: The company offers sepsis therapeutics solutions such as Adrecizumab.

  • AM Pharma BV
  • Astellas Pharma Inc
  • AstraZeneca Plc
  • bioMerieux SA
  • CytoSorbents Corp.
  • F. Hoffmann La Roche Ltd.
  • Hikma Pharmaceuticals Plc
  • Inotrem S.A.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Spectral Medical Inc.
  • Takeda Pharmaceutical Co. Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Analyst Overview

The market encompasses a range of treatments aimed at combating this life-threatening condition. From septic shock treatment to antibiotics, the focus is on swift sepsis diagnosis and effective infection control within the Intensive Care Unit (ICU). Therapeutic approaches include the use of anti-inflammatory drugs to modulate the immune response and targeted blood infection treatment to manage septicemia. Adherence to sepsis guidelines and advancements in critical care medicine are crucial in improving sepsis management and reducing sepsis mortality rates. Ongoing sepsis research seeks to deepen understanding of sepsis pathophysiology, enhance sepsis symptoms recognition, and refine sepsis prevention strategies for better sepsis prognosis.

Key Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Market Customer Landscape

Segment Overview

The market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2018 to 2028. 

  • Application Outlook
    • Hospitals
    • Clinics
    • Others
  • Type Outlook
    • Antimicrobial therapy
    • Adjunctive therapy
  • Geography Outlook
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • Rest of the World (ROW)
      • Australia
      • Argentina
      • Brazil

Market Scope

Report Coverage

Details

Page number

157

Base year

2023

Historic period

2018-2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 6.98%

Market Growth 2024-2028

USD 1.42 billion

Market structure

Fragmented

YoY growth 2023-2024(%)

6.78

Regional analysis

North America, Europe, APAC, South America, and Middle East and Africa

Performing market contribution

North America at 35%

Key countries

US, China, Japan, Germany, and UK

Competitive landscape

 Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

Adrenomed AG, AM Pharma BV, Astellas Pharma Inc., AstraZeneca Plc, bioMerieux SA, CytoSorbents Corp., F. Hoffmann La Roche Ltd., Hikma Pharmaceuticals Plc, Inotrem S.A., Novartis AG, Pfizer Inc., Sanofi SA, Spectral Medical Inc., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc.

Market dynamics

Parent market analysis, market growth and forecasting inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the market between 2024 and 2028
  • Precise estimation of the market size and its contribution to the market in focus on the parent market
  • Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
  • Companies landscape comparing criticality of inputs and factors of differentiation
  • Exclusive Matrix on companies position and classification
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market across North America, Europe, APAC, South America, and Middle East and Africa
  • A thorough analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Type
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2023
    • 3.4 Market outlook: Forecast for 2023-2028
      • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

    4 Historic Market Size

    • 4.1 Global sepsis therapeutics market 2018 - 2022
      • Exhibit 18: Historic Market Size – Data Table on global sepsis therapeutics market 2018 - 2022 ($ billion)
    • 4.2 Application Segment Analysis 2018 - 2022
      • Exhibit 19: Historic Market Size – Application Segment 2018 - 2022 ($ billion)
    • 4.3 Type Segment Analysis 2018 - 2022
      • Exhibit 20: Historic Market Size – Type Segment 2018 - 2022 ($ billion)
    • 4.4 Geography Segment Analysis 2018 - 2022
      • Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ billion)
    • 4.5 Country Segment Analysis 2018 - 2022
      • Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ billion)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

    6 Market Segmentation by Application

    • 6.1 Market segments
      • Exhibit 30: Chart on Application - Market share 2023-2028 (%)
      • Exhibit 31: Data Table on Application - Market share 2023-2028 (%)
    • 6.2 Comparison by Application
      • Exhibit 32: Chart on Comparison by Application
      • Exhibit 33: Data Table on Comparison by Application
    • 6.3 Hospitals - Market size and forecast 2023-2028
      • Exhibit 34: Chart on Hospitals - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 35: Data Table on Hospitals - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 36: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
      • Exhibit 37: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
    • 6.4 Clinics - Market size and forecast 2023-2028
      • Exhibit 38: Chart on Clinics - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 39: Data Table on Clinics - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 40: Chart on Clinics - Year-over-year growth 2023-2028 (%)
      • Exhibit 41: Data Table on Clinics - Year-over-year growth 2023-2028 (%)
    • 6.5 Others - Market size and forecast 2023-2028
      • Exhibit 42: Chart on Others - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 43: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 44: Chart on Others - Year-over-year growth 2023-2028 (%)
      • Exhibit 45: Data Table on Others - Year-over-year growth 2023-2028 (%)
    • 6.6 Market opportunity by Application
      • Exhibit 46: Market opportunity by Application ($ billion)
      • Exhibit 47: Data Table on Market opportunity by Application ($ billion)

    7 Market Segmentation by Type

    • 7.1 Market segments
      • Exhibit 48: Chart on Type - Market share 2023-2028 (%)
      • Exhibit 49: Data Table on Type - Market share 2023-2028 (%)
    • 7.2 Comparison by Type
      • Exhibit 50: Chart on Comparison by Type
      • Exhibit 51: Data Table on Comparison by Type
    • 7.3 Antimicrobial therapy - Market size and forecast 2023-2028
      • Exhibit 52: Chart on Antimicrobial therapy - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 53: Data Table on Antimicrobial therapy - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 54: Chart on Antimicrobial therapy - Year-over-year growth 2023-2028 (%)
      • Exhibit 55: Data Table on Antimicrobial therapy - Year-over-year growth 2023-2028 (%)
    • 7.4 Adjunctive therapy - Market size and forecast 2023-2028
      • Exhibit 56: Chart on Adjunctive therapy - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 57: Data Table on Adjunctive therapy - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 58: Chart on Adjunctive therapy - Year-over-year growth 2023-2028 (%)
      • Exhibit 59: Data Table on Adjunctive therapy - Year-over-year growth 2023-2028 (%)
    • 7.5 Market opportunity by Type
      • Exhibit 60: Market opportunity by Type ($ billion)
      • Exhibit 61: Data Table on Market opportunity by Type ($ billion)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 63: Chart on Market share by geography 2023-2028 (%)
      • Exhibit 64: Data Table on Market share by geography 2023-2028 (%)
    • 9.2 Geographic comparison
      • Exhibit 65: Chart on Geographic comparison
      • Exhibit 66: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2023-2028
      • Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
      • Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
    • 9.4 Europe - Market size and forecast 2023-2028
      • Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
      • Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
    • 9.5 APAC - Market size and forecast 2023-2028
      • Exhibit 75: Chart on APAC - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 76: Data Table on APAC - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 77: Chart on APAC - Year-over-year growth 2023-2028 (%)
      • Exhibit 78: Data Table on APAC - Year-over-year growth 2023-2028 (%)
    • 9.6 South America - Market size and forecast 2023-2028
      • Exhibit 79: Chart on South America - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 80: Data Table on South America - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 81: Chart on South America - Year-over-year growth 2023-2028 (%)
      • Exhibit 82: Data Table on South America - Year-over-year growth 2023-2028 (%)
    • 9.7 Middle East and Africa - Market size and forecast 2023-2028
      • Exhibit 83: Chart on Middle East and Africa - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 84: Data Table on Middle East and Africa - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 85: Chart on Middle East and Africa - Year-over-year growth 2023-2028 (%)
      • Exhibit 86: Data Table on Middle East and Africa - Year-over-year growth 2023-2028 (%)
    • 9.8 US - Market size and forecast 2023-2028
      • Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
      • Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
    • 9.9 Germany - Market size and forecast 2023-2028
      • Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
      • Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
    • 9.10 China - Market size and forecast 2023-2028
      • Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
      • Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
    • 9.11 Japan - Market size and forecast 2023-2028
      • Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
      • Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
    • 9.12 UK - Market size and forecast 2023-2028
      • Exhibit 103: Chart on UK - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 104: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 105: Chart on UK - Year-over-year growth 2023-2028 (%)
      • Exhibit 106: Data Table on UK - Year-over-year growth 2023-2028 (%)
    • 9.13 Market opportunity by geography
      • Exhibit 107: Market opportunity by geography ($ billion)
      • Exhibit 108: Data Tables on Market opportunity by geography ($ billion)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 109: Impact of drivers and challenges in 2023 and 2028
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 111: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 112: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 113: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 114: Matrix on vendor position and classification
            • 12.3 Adrenomed AG
              • Exhibit 115: Adrenomed AG - Overview
              • Exhibit 116: Adrenomed AG - Product / Service
              • Exhibit 117: Adrenomed AG - Key offerings
            • 12.4 Astellas Pharma Inc.
              • Exhibit 118: Astellas Pharma Inc. - Overview
              • Exhibit 119: Astellas Pharma Inc. - Product / Service
              • Exhibit 120: Astellas Pharma Inc. - Key news
              • Exhibit 121: Astellas Pharma Inc. - Key offerings
            • 12.5 AstraZeneca Plc
              • Exhibit 122: AstraZeneca Plc - Overview
              • Exhibit 123: AstraZeneca Plc - Product / Service
              • Exhibit 124: AstraZeneca Plc - Key news
              • Exhibit 125: AstraZeneca Plc - Key offerings
            • 12.6 bioMerieux SA
              • Exhibit 126: bioMerieux SA - Overview
              • Exhibit 127: bioMerieux SA - Product / Service
              • Exhibit 128: bioMerieux SA - Key offerings
            • 12.7 CytoSorbents Corp.
              • Exhibit 129: CytoSorbents Corp. - Overview
              • Exhibit 130: CytoSorbents Corp. - Product / Service
              • Exhibit 131: CytoSorbents Corp. - Key offerings
            • 12.8 F. Hoffmann La Roche Ltd.
              • Exhibit 132: F. Hoffmann La Roche Ltd. - Overview
              • Exhibit 133: F. Hoffmann La Roche Ltd. - Business segments
              • Exhibit 134: F. Hoffmann La Roche Ltd. - Key news
              • Exhibit 135: F. Hoffmann La Roche Ltd. - Key offerings
              • Exhibit 136: F. Hoffmann La Roche Ltd. - Segment focus
            • 12.9 Hikma Pharmaceuticals Plc
              • Exhibit 137: Hikma Pharmaceuticals Plc - Overview
              • Exhibit 138: Hikma Pharmaceuticals Plc - Business segments
              • Exhibit 139: Hikma Pharmaceuticals Plc - Key offerings
              • Exhibit 140: Hikma Pharmaceuticals Plc - Segment focus
            • 12.10 Inotrem S.A.
              • Exhibit 141: Inotrem S.A. - Overview
              • Exhibit 142: Inotrem S.A. - Product / Service
              • Exhibit 143: Inotrem S.A. - Key offerings
            • 12.11 Novartis AG
              • Exhibit 144: Novartis AG - Overview
              • Exhibit 145: Novartis AG - Business segments
              • Exhibit 146: Novartis AG - Key offerings
              • Exhibit 147: Novartis AG - Segment focus
            • 12.12 Pfizer Inc.
              • Exhibit 148: Pfizer Inc. - Overview
              • Exhibit 149: Pfizer Inc. - Product / Service
              • Exhibit 150: Pfizer Inc. - Key news
              • Exhibit 151: Pfizer Inc. - Key offerings
            • 12.13 Sanofi SA
              • Exhibit 152: Sanofi SA - Overview
              • Exhibit 153: Sanofi SA - Business segments
              • Exhibit 154: Sanofi SA - Key news
              • Exhibit 155: Sanofi SA - Key offerings
              • Exhibit 156: Sanofi SA - Segment focus
            • 12.14 Spectral Medical Inc.
              • Exhibit 157: Spectral Medical Inc. - Overview
              • Exhibit 158: Spectral Medical Inc. - Product / Service
              • Exhibit 159: Spectral Medical Inc. - Key offerings
            • 12.15 Takeda Pharmaceutical Co. Ltd.
              • Exhibit 160: Takeda Pharmaceutical Co. Ltd. - Overview
              • Exhibit 161: Takeda Pharmaceutical Co. Ltd. - Product / Service
              • Exhibit 162: Takeda Pharmaceutical Co. Ltd. - Key news
              • Exhibit 163: Takeda Pharmaceutical Co. Ltd. - Key offerings
            • 12.16 Teva Pharmaceutical Industries Ltd.
              • Exhibit 164: Teva Pharmaceutical Industries Ltd. - Overview
              • Exhibit 165: Teva Pharmaceutical Industries Ltd. - Business segments
              • Exhibit 166: Teva Pharmaceutical Industries Ltd. - Key news
              • Exhibit 167: Teva Pharmaceutical Industries Ltd. - Key offerings
              • Exhibit 168: Teva Pharmaceutical Industries Ltd. - Segment focus
            • 12.17 Viatris Inc.
              • Exhibit 169: Viatris Inc. - Overview
              • Exhibit 170: Viatris Inc. - Business segments
              • Exhibit 171: Viatris Inc. - Key news
              • Exhibit 172: Viatris Inc. - Key offerings
              • Exhibit 173: Viatris Inc. - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 174: Inclusions checklist
                • Exhibit 175: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 176: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 177: Research methodology
                • Exhibit 178: Validation techniques employed for market sizing
                • Exhibit 179: Information sources
              • 13.5 List of abbreviations
                • Exhibit 180: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              sepsis therapeutics market market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis